Studies published in NEJM identify promising drug therapies for fatal lung disease

Director of Women's Guild Lung Institute at Cedars-Sinai authors studies on potential treatments

2014-05-19

(Press-News.org) LOS ANGELES (May 18, 2014) – Researchers in separate clinical trials found two drugs slow the progression of idiopathic pulmonary fibrosis, a fatal lung disease with no effective treatment or cure, and for which there is currently no therapy approved by the Food and Drug Administration.

Paul W. Noble, MD, chair of the Department of Medicine at Cedars-Sinai and director of the Women's Guild Lung Institute, is the senior author of the multicenter study that found that the investigational drug pirfenidone significantly slowed the loss of lung function and reduced the risk of death. Pirfenidone was developed by InterMune Inc. and in 2011 was approved by the European Union for the treatment of idiopathic pulmonary fibrosis.

The findings of the ASCEND drug trial are published online by the New England Journal of Medicine and are being presented this week at the International Conference of the American Thoracic Society in San Diego. "What we discovered about the anti-inflammatory and anti-fibrotic properties of pirfenidone offers help and encouragement to so many patients suffering from this relentless disease that robs them of breath and life," said Noble.

Idiopathic pulmonary fibrosis causes the regions of the lungs where oxygen gets to the blood to thicken and scar, leaving patients with shortness of breath, a chronic cough and extreme fatigue. Most patients die within two to five years of diagnosis.

"Not only did pirfenidone prevent the loss of lung function and preserve the distance patients could walk, but during the study the risk of death was reduced by a remarkable 48 percent in those taking the drug when compared with those who received placebo," said Noble." The findings were so strong that an early access program has been initiated to provide patients with pirfenidone while the process of obtaining FDA approval is undertaken. Cedars-Sinai will be participating in this program under the direction of Dr. Jeremy Falk and the Advanced Lung Disease Program.

Noble also was a co-author of a second study testing the efficacy and safety of the multi-kinase inhibitor nintedanib on idiopathic pulmonary fibrosis patients. Nintedanib is also is being studied in lung cancer.

"In our research we found that nintedanib could also slow the loss of lung function in patients with idiopathic pulmonary fibrosis," said Noble. "It is a second dose of good news for our patients because nintedanib not only slowed the progression of the disease, but it tended to reduce acute exacerbations of the disease, while tending to preserve the quality of life of the study patients receiving the drug." Noble is a paid consultant of InterMune Inc. and Boehringer-Ingelheim for his work on the steering committees of the two clinical trials. Cedars--Sinai was not among the medical centers participating in this multicenter study of the drug's efficacy in treating idiopathic pulmonary fibrosis.

"These IPF drug therapy findings by Dr. Noble and his colleagues exemplify the dedication and hard work required to find treatments for a group of patients who have so few therapeutic options because there have been no drugs approved by the Food and Drug Administration specifically targeted for treating this fatal disease," said Shlomo Melmed, MD, senior vice president and dean at Cedars-Sinai and the Helene A. and Philip E. Hixon Chair in Investigative Medicine.

INFORMATION: END

ELSE PRESS RELEASES FROM THIS DATE:

EPA ToxCast data validates BioMAP® systems' ability to predict drug, chemical toxicities

2014-05-19

FREMONT, CA (May 19, 2014): Newly published research demonstrates the ability of BioMAP® Systems, a unique set of primary human cell and co-culture assays that model human disease and pathway biology, to identify important safety aspects of drugs and chemicals more efficiently and accurately than can be achieved by animal testing. Data from BioMAP Systems analysis of 776 environmental chemicals, including reference pharmaceuticals and failed drugs, on their ability to disrupt physiologically important human biological pathways were published online this week in Nature ...

Fluoridating water does not lower IQ: New Zealand research

2014-05-19

New research out of New Zealand's world-renowned Dunedin Multidisciplinary Study does not support claims that fluoridating water adversely affects children's mental development and adult IQ. The researchers were testing the contentious claim that exposure to levels of fluoride used in community water fluoridation is toxic to the developing brain and can cause IQ deficits. Their findings are newly published in the highly respected American Journal of Public Health. The Dunedin Study has followed nearly all aspects of the health and development of around 1000 people born ...

Chinese scientists crack the genome of another diploid cotton Gossypium arboreum

2014-05-19

Shenzhen, May 18, 2014---Chinese scientists from Chinese Academy of Agricultural Sciences and BGI successfully deciphered the genome sequence of another diploid cotton-- Gossypium arboreum (AA) after the completed sequencing of G. raimondii (DD) in 2012. G. arboreum, a cultivated cotton, is a putative contributor for the A subgenome of cotton. Its completed genome will play a vital contribution to the future molecular breeding and genetic improvement of cotton and its close relatives. The latest study today was published online in Nature Genetics. As one of the most ...

The young sperm, poised for greatness

2014-05-19

SALT LAKE CITY— In the body, a skin cell will always be skin, and a heart cell will always be heart. But in the first hours of life, cells in the nascent embryo become totipotent: they have the incredible flexibility to mature into skin, heart, gut, or any type of cell. It was long assumed that the joining of egg and sperm launched a dramatic change in how and which genes were expressed. Instead, new research shows that totipotency is a step-wise process, manifesting as early as in precursors to sperm, called adult germline stem cells (AGSCs), which reside in the testes. ...

'Smoking gun' evidence for theory that Saturn's collapsing magnetic tail causes auroras

2014-05-19

University of Leicester researchers have captured stunning images of Saturn's auroras as the planet's magnetic field is battered by charged particles from the Sun. The team's findings provide a "smoking gun" for the theory that Saturn's auroral displays are often caused by the dramatic collapse of its "magnetic tail". Just like comets, planets such as Saturn and the Earth have a "tail" – known as the magnetotail – that is made up of electrified gas from the Sun and flows out in the planet's wake. When a particularly strong burst of particles from the Sun hits Saturn, ...

Solar energy prospects are bright for Scotland, experts say

2014-05-19

Installing state-of-the-art solar panels on a quarter of a million roofs could meet one-sixth of Scotland's electricity demands, experts say. Scientists say the strategy could ease the plight of one in three Scottish households, which currently struggle to provide themselves with adequate heat and hot water. Researchers, business leaders and public sector experts have contributed to a report which sets out how Scotland could benefit from solar power. They say harnessing energy from the sun on the roofs of south-facing buildings could have significant economic, ...

Antarctica's ice losses on the rise

2014-05-19

Three years of observations show that the Antarctic ice sheet is now losing 159 billion tonnes of ice each year – twice as much as when it was last surveyed. A team of scientists from the UK Centre for Polar Observation and Modelling, led by researchers at the University of Leeds, have produced the first complete assessment of Antarctic ice sheet elevation change. They used measurements collected by the European Space Agency's CryoSat-2 satellite mission, which carries an altimeter specially designed for this task. In sharp contrast to past altimeter missions, CryoSat-2 ...

Sanofi Pasteur announces favorable Phase II data for investigational C. difficile vaccine

2014-05-19

Boston, United States of America – May 19, 2014 – Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), presented Phase II (H-030-012) trial results for an investigational vaccine for the prevention of Clostridium difficile (C. diff) infection (CDI) at the 114th General Meeting of the American Society for Microbiology (ASM). The Phase II trial met its primary objectives, reactions were generally mild and of short duration, and the candidate vaccine generated an immune response against C. diff toxins A and B. These toxins are largely responsible ...

Your high school GPA could affect your income

2014-05-19

Coral Gables, Fla. (May 19, 2014)—A team of researchers led by Michael T. French, professor of health economics at the University of Miami (UM), finds that high school grade point average (GPA) is a strong predictor of future earnings. The findings, published recently in the Eastern Economic Journal, show that a one-point increase in high school GPA raises annual earnings in adulthood by around 12 percent for men and 14 percent for women. Although previous studies have found a relationship between higher levels of education and greater earnings, less is known about ...

Keywords hold vocabulary together in memory

2014-05-19

Much like key players in social networks, University of Kansas scientists have found evidence that there are keywords in word networks that hold together groups of words in our memory. In a study published in the Journal of Memory and Language, Michael Vitevitch, KU professor of psychology, showed that research participants recognized these keywords more quickly and accurately than other words that were like the keywords in many respects except for their position in a network of 20,000 similar-sounding English words that he and colleagues created in 2008. "If words ...